Bloomberg the Company

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech


156.7900 USD 2.1000 1.32%

As of 11:44:35 ET on 01/28/2015.

Company Profile for Amgen Inc (AMGN)

Amgen Inc. is an independent biotechnology medicines company that discovers, develops, manufactures and markets medicines for grievous illnesses. The Company focuses solely on human therapeutics and concentrates on innovating novel medicines based on advances in cellular and molecular biology.

Contact Information

Amgen Inc

One Amgen Center Drive
Building 27
Thousand Oaks, CA 91320-1799
United States
Phone: 1-805-447-1000
Fax: 1-805-447-1010

Key Executives for Amgen Inc (AMGN)

Robert A Bradway "Bob"Chairman/President/CEODavid W MelineExec VP/CFO
Anthony C Hooper "Tony"Exec VP:Global Commercial OpsBrian M McNameeExec VP:Full Potential Initiatives
Madhavan BalachandranExec VP:OperationsSean E HarperExec VP:Research & Dev
David J ScottSenior VP/Secy/Gen CnslStuart A TrossSenior VP:Human Resources
Martin VantriesteSenior VP:QualityArvind SoodVP:Investor Relations

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

sec ||= nil